VC firms
Bonaventure Equity, LLC (“BVE”) is a collaboration of partners, founders, and researchers tackling healthcare’s biggest challenges. Together we work in service of patients everywhere to advance the therapeutic potential of controlled substances through science, entrepreneurship, and policy.
Overview
Investment Type
Venture Capital
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 26, 2022 | Bonaventure Equity Announces Follow-On Investment in Engineered Medical Technologies (tCheck) | www.bve.vc BVE has supplied tCheck with resources and relationships, and with this further infusion of capital, we will continue to support their operations, regulatory strategy, and fundraising objectives.” — Ross O'BrienRALEIGH, NC, USA, ... |
| Apr 11, 2022 | Bonaventure Equity Announces the Appointment of Robert J. Toth, Jr. to the Position of Scientific Operating Partner | www.bve.vc Seasoned biotechnology executive joins BVE’s cannabis and psilocybin life sciences fund. We believe there is no one more qualified than Rob to critically evaluate and help build long term value in the innovative life sciences com... |
Reviews 0
FAQ about Bonaventure Equity
What has the press written about Bonaventure Equity?
Parsers VC has collected 3 articles mentioning Bonaventure Equity, among them “Bonaventure Equity Announces Follow-On Investment in Engineered Medical Technologies (tCheck)” (May 26, 2022) and “Bonaventure Equity Announces the Appointment of Robert J. Toth, Jr. to the Position of Scientific Operating Partner” (Apr 11, 2022).
Is Bonaventure Equity still active?
Yes, Bonaventure Equity is active; its latest activity on Parsers VC dates from Jul 19, 2022.